Meta facebook tracking pixel

Program Status:  

Closed

Unfortunately, this fund is currently closed. Funds will open and close periodically throughout the year, so please check our website frequently for the most up-to-date fund status.

To receive an email notification when this fund re-opens, click the register button below. We recommend using Google Chrome browser to avoid possible issues.

Register to receive email notification when fund re-opens

Eligibility Criteria

Diagnosis:

• Primary cancer diagnosis must be the same as the fund and verified by the prescribing physician. Download Physician Verification Form »

Insurance:
• Patient must have health care insurance (any type)

Income:
• Income level must be at or below 500% of the Federal Poverty Level (FPL)

Citizenship:
• Must have a valid Social Security number to apply for assistance and receive treatment in the United States

Treatments Covered:
• Patient must be in active treatment or have a treatment plan in place prior to applying for assistance. Read more in our FAQs »

Retroactive policy

CCAF will consider retroactive reimbursement for first time applicants actively receiving a covered treatment. Our retroactive assistance will only consider dates of service within 60 days prior to the date we approve the application. Conditional approvals are not eligible for retroactive coverage.

Initial Grant Amount

$4,000

Program CAP Amount

$10,000

If the initial grant amount is exhausted before the grant end date, a request for additional funds up to the program CAP amount can be submitted. Read our Request for Additional Funds policy »

Additional Services

CancerCare offers support services for people with glioblastoma including counseling, support groups, financial assistance, workshops and publications.

View All Services

« Back to Co-Payment Funding
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.